A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
Clinical trial NCT05736406 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05736406
- Sponsor
- Hemerion Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-20
- Primary completion
- 2026-03-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.